여행용 백신 시장 규모, 점유율, 성장 분석 : 백신 종류별, 질병별, 여행자 유형별, 지역별 - 업계 예측(2025-2032년)

Global Travel Vaccines Market size was valued at USD 4.1 billion in 2023 and is poised to grow from USD 4.31 billion in 2024 to USD 6.47 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The global travel vaccines market is experiencing significant growth propelled by various factors influencing both demand and supply dynamics. Increased global travel for leisure, business, and education has intensified the need for vaccinations, as travelers encounter region-specific infections. The thriving tourism sector, particularly eco-tourism and adventure travel to remote locations, underscores the critical nature of vaccination. Heightened public and governmental awareness of infectious disease outbreaks further drives vaccine demand. Regulatory mandates in numerous countries necessitating proof of vaccination for entry enhance compliance and market demand. Innovations in vaccine development, particularly through mRNA and recombinant technologies, improve efficacy and expedite creation, fostering greater reliance on these products. Additionally, rising healthcare costs and initiatives by public health agencies to educate travelers and promote immunization open new market opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Travel Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Travel Vaccines Market Segments Analysis

Global Travel Vaccines Market is segmented by Vaccine Type, Disease, Traveler Type and region. Based on Vaccine Type, the market is segmented into Mono Vaccines and Combination Vaccines. Based on Disease, the market is segmented into Hepatitis A, Hepatitis B, Typhoid, Yellow Fever, Rabies, Meningococcal, Japanese Encephalitis, Measles & Mumps and Others. Based on Traveler Type, the market is segmented into Outbound Travelers, Inbound Travelers, Business Travel and Leisure Travel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Travel Vaccines Market

A key market driver for the global travel vaccines market is the increasing international travel and tourism, which has significantly enhanced the risk of exposure to infectious diseases. As more individuals embark on international trips for leisure, business, or study, the need for preventative healthcare measures, including vaccinations, becomes paramount to safeguard health. Rising public awareness regarding vaccine-preventable diseases and recommendations from health authorities further propel the demand for travel vaccines. Additionally, factors such as globalization, diverse travel destinations, and varying health regulations strengthen the inclination for immunization prior to travel, fostering growth in the travel vaccines market.

Restraints in the Global Travel Vaccines Market

One key market restraint for the global travel vaccines market is the varying regulatory frameworks and approval processes across different countries. Each nation establishes its own guidelines for vaccine administration, which can lead to discrepancies in availability and acceptance. Additionally, the hesitance towards vaccinations due to misinformation or cultural beliefs can further inhibit market growth. Travel restrictions and geopolitical factors can also limit the accessibility of vaccines in certain regions. As travelers seek assurance regarding vaccine safety and efficacy, inconsistent regulatory practices may hinder the overall confidence and uptake of travel vaccines globally.

Market Trends of the Global Travel Vaccines Market

The Global Travel Vaccines market is witnessing a significant transformation driven by the integration of advanced vaccine technologies. Innovations such as mRNA, recombinant, and single-dose platforms are enabling faster responses to emerging global health threats while enhancing vaccine efficacy and improving distribution efficiencies. The success of mRNA platforms, highlighted during the COVID-19 pandemic, has prompted major companies to invest heavily in research for new and combination travel vaccines tailored to the evolving demands of contemporary travelers. This proactive approach not only addresses current healthcare needs but also anticipates future vaccine regulation changes, positioning the market for sustained growth and adaptability.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Travel Vaccines Market Size by Vaccine Type & CAGR (2025-2032)

• Market Overview
• Mono Vaccines
• Combination Vaccines

Global Travel Vaccines Market Size by Disease & CAGR (2025-2032)

• Market Overview
• Hepatitis A
• Hepatitis B
• Typhoid
• Yellow Fever
• Rabies
• Meningococcal
• Japanese Encephalitis
• Measles & Mumps
• Others

Global Travel Vaccines Market Size by Traveler Type & CAGR (2025-2032)

• Market Overview
• Outbound Travelers
• Inbound Travelers
• Business Travel
• Leisure Travel

Global Travel Vaccines Market Size & CAGR (2025-2032)

• North America (Vaccine Type, Disease, Traveler Type)
  • US
  • Canada
• Europe (Vaccine Type, Disease, Traveler Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Disease, Traveler Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Disease, Traveler Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Disease, Traveler Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LG Chem Ltd. (Life Sciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Tanabe Pharma Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations